Literature DB >> 27250491

[Inflammation and bone : Osteoimmunological aspects].

K W Frommer1, E Neumann2, U Lange2.   

Abstract

Microscopic fractures (so-called microcracks) or traumatic macrofractures require bone, as the basic scaffold of the human body, to have a high regenerative capability. In order to be able to provide this regenerative capability, bone is in a constant process of remodeling. This finely tuned homeostasis of bone formation and degradation can become disrupted, which leads to osteoporosis or other bone disorders. It has been shown that the immune system is substantially involved in the regulation of bone homeostasis and that chronic inflammation in particular can disturb this balance; therefore, this article reviews the osteoimmunological aspects contributing to osteoporosis and other diseases associated with bone degradation.

Entities:  

Keywords:  Degeneration; Fractures; Homeostasis; Osteoporosis; Regeneration

Mesh:

Substances:

Year:  2016        PMID: 27250491     DOI: 10.1007/s00393-016-0101-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  29 in total

1.  Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.

Authors:  Frederic Morvan; Kim Boulukos; Philippe Clément-Lacroix; Sergio Roman Roman; Isabelle Suc-Royer; Béatrice Vayssière; Patrick Ammann; Patrick Martin; Sonia Pinho; Philippe Pognonec; Patrick Mollat; Christof Niehrs; Roland Baron; Georges Rawadi
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

Review 2.  Wnt signaling in bone metabolism.

Authors:  Takuo Kubota; Toshimi Michigami; Keiichi Ozono
Journal:  J Bone Miner Metab       Date:  2009-03-31       Impact factor: 2.626

3.  High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study.

Authors:  Georg Schett; Stefan Kiechl; Siegfried Weger; Angelo Pederiva; Agnes Mayr; Manuele Petrangeli; Friedrich Oberhollenzer; Rolando Lorenzini; Kurt Redlich; Roland Axmann; Jochen Zwerina; Johann Willeit
Journal:  Arch Intern Med       Date:  2006 Dec 11-25

4.  CTLA-4 directly inhibits osteoclast formation.

Authors:  R Axmann; S Herman; M Zaiss; S Franz; K Polzer; J Zwerina; M Herrmann; J Smolen; G Schett
Journal:  Ann Rheum Dis       Date:  2008-01-18       Impact factor: 19.103

5.  Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.

Authors:  J S Smolen; C Han; D M F M van der Heijde; P Emery; J M Bathon; E Keystone; R N Maini; J R Kalden; D Aletaha; D Baker; J Han; M Bala; E W St Clair
Journal:  Ann Rheum Dis       Date:  2008-07-01       Impact factor: 19.103

6.  Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis.

Authors:  A Gough; P Sambrook; J Devlin; A Huissoon; C Njeh; S Robbins; T Nguyen; P Emery
Journal:  J Rheumatol       Date:  1998-07       Impact factor: 4.666

7.  Treg cells suppress osteoclast formation: a new link between the immune system and bone.

Authors:  Mario M Zaiss; Roland Axmann; Jochen Zwerina; Karin Polzer; Eva Gückel; Alla Skapenko; Hendrik Schulze-Koops; Nikki Horwood; Andrew Cope; Georg Schett
Journal:  Arthritis Rheum       Date:  2007-12

Review 8.  TGF-β and BMP signaling in osteoblast differentiation and bone formation.

Authors:  Guiqian Chen; Chuxia Deng; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2012-01-21       Impact factor: 6.580

9.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.

Authors:  Kojiro Sato; Ayako Suematsu; Kazuo Okamoto; Akira Yamaguchi; Yasuyuki Morishita; Yuho Kadono; Sakae Tanaka; Tatsuhiko Kodama; Shizuo Akira; Yoichiro Iwakura; Daniel J Cua; Hiroshi Takayanagi
Journal:  J Exp Med       Date:  2006-11-06       Impact factor: 14.307

Review 10.  Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases.

Authors:  Qian Zhang; Bin Chen; Fuhua Yan; Jianbin Guo; Xiaofeng Zhu; Shouzhi Ma; Wenrong Yang
Journal:  Biomed Res Int       Date:  2014-02-16       Impact factor: 3.411

View more
  3 in total

1.  IL-21 Enhances the Degradation of Cartilage Through the JAK-STAT Signaling Pathway During Osteonecrosis of Femoral Head Cartilage.

Authors:  Bin Chen; Yi Liu; Lei Cheng
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  Differential expression of genes associated with hypoxia pathway on bone marrow stem cells in osteoporosis patients with different bone mass index.

Authors:  Qi Zhu; Chang Shan; Ling Li; Lige Song; Keqin Zhang; Yun Zhou
Journal:  Ann Transl Med       Date:  2019-07

3.  Hip Osteonecrosis Is Associated with Increased Plasma IL-33 Level.

Authors:  Jinhui Ma; Wanshou Guo; Zirong Li; Bailiang Wang; Shirui Li; Peng Wang
Journal:  Mediators Inflamm       Date:  2017-01-11       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.